Stocks and Investing
Stocks and Investing
Thu, June 8, 2023
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
Hartaj Singh Reiterated (ATXS) at Buy and Held Target at $30 on, Jun 8th, 2023
Hartaj Singh of Oppenheimer, Reiterated "Astria Therapeutics, Inc." (ATXS) at Buy and Held Target at $30 on, Jun 8th, 2023.
Hartaj has made no other calls on ATXS in the last 4 months.
There are 3 other peers that have a rating on ATXS. Out of the 3 peers that are also analyzing ATXS, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Hartaj
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Friday, May 12th, 2023
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $26 on, Friday, May 12th, 2023
- Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $18 on, Tuesday, March 28th, 2023
Contributing Sources